Evaluation of the clinical value of carbon nanoparticles in endoscopic thyroidectomy and prophylactic central neck dissection through total mammary areolas approach for thyroid cancer

Table 1 Demographic data and surgical outcomes of patients undergoing endoscopic thyroidectomy with CN group versus control group

Variables	CN	Control	p value
Age, mean ± SD	34.7 ± 9.8	35.0 ± 9.1	0.834
Gender
Male	2	2	0.581
Female	52	70	0.581
Tumor size (mm, mean ± SD)	8.7 ± 2.8	8.8 ± 2.6	0.944
Extent of surgery
TT+ CND	15	20	0.562
HT+ CND	39	52	0.562
Operation time (mins, mean ± SD)
TT+ CND	129.3 ± 16.7	125.0 ± 23.7	0.550
LT+ CND	88.0 ± 10.5	87.1 ± 11.5	0.708
Postoperative hoarseness cases
Transient	3	4	0.650
Permanent	1	2	0.607
Hypoparathyroidism
Transient	5	7	0.581
Permanent	0	0	-
PTH levels (day 1, pg/ml)
Without TH	30.0 ± 10.0	29.3 ± 9.4	0.716
With TH	8.2 ± 2.6	8.7 ±3.2	0.774
PTH levels (day 3)
Without TH	30.5 ± 10.4	29.5 ± 9.8	0.590
With TH	8.8 ± 1.6	9.4 ± 2.6	0.643
PTH levels (month 3)	34.3 ± 8.4	32.3 ± 7.1	0.141
Hematoma/seroma	1	0	0.432
Paresthesia of chest wall
Within 3 months after surgery	10	13	0.578
Three months after surgery	0	1	0.429
Recurrence	0	0	-

TT total thyroidectomy, HT hemithyroidectomy, CND central neck dissection, PGs parathyroid glands, TH transient hypoparathyroidism

ISSN: 1477-7819